SGLT2 Inhibitors in Heart Failure and Comorbidities: Multidimensional Mechanisms and Clinical Evidence
Heart failure and diabetes mellitus frequently coexist. These two conditions mutually exacerbate each other, significantly increasing the risks of cardiovascular death and rehospitalization. Sodium–glucose cotransporter 2 inhibitors have demonstrated unexpected and profound cardioprotective effects beyond glycemic cont...